Elicker John E

Avg. Two Year Performance

No purchase track record

(9%) Avg. Sale Return

(4%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	2%	4%	< 1%	(3%)	(9%)
Sale Success Rate	5 of 9	5 of 9	3 of 9	3 of 9	2 of 9

Bristol-Myers Squibb Co.

Drugs » Drug Manufacturers - Major

EVP, Investor Relations:

Holdings: 70.95K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--